Soluble Mannose 6-Phosphate/Insulin-Like Growth Factor II (IGF-II) Receptor Inhibits Interleukin-6-Type Cytokine-Dependent Proliferation by Neutralization of IGF-II

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5381-5389

  Duplomb, Laurence ^a,b   Chaigne Delalande, Benjamin ^a   Vusio, Patricia ^a   Raher, Sylvie ^a   Jacques, Yannick ^a   Godard, Anne ^a   Blanchard, Frédéric ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; INSULIN LIKE GROWTH FACTOR ANTIBODY; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; BONE MARROW CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOID CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CHO CELLS; CRICETINAE; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-11; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 2; SIGNAL TRANSDUCTION; SOLUBILITY; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0344394260     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0607     Document Type: Article

References (48)

1. Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF 1998 Leukemia inhibitory factor: part of a large ingathering family. Int Rev Immunol 16:397-426
2. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L 1998 Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334:297-314
3. Peters M, Muller AM, Rose-John S 1998 Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92:3495-3504
4. Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez-Ramos JC 1994 Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1:725-731
5. Nakahata T 2001 Ex vivo expansion of human hematopoietic stem cells. Int J Hematol 73:6-13
6. Banchereau J, Rousset F 1992 Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol 52:125-262
7. Barille S, Bataille R, Amiot M 2000 The role of interleukin-6 and interleukin-6/interleukin-6 receptor-α complex in the pathogenesis of multiple myeloma. Eur Cytokine Network 11:546-551
8. Wang YD, De Vos J, Jourdan M, Couderc G, Lu ZY, Rossi JF, Klein B 2002 Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Oncogene 21:2584-2592
9. Ferlin M, Noraz N, Hertogh C, Brochier J, Taylor N, Klein B 2000 Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. Br J Haematol 111:626-634
10. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T 1996 Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in antiapoptosis. Immunity 5:449-460
11. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T 1998 STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 17:6670-6677
12. Blanchard F, Raher S, Duplomb L, Vusio P, Pitard V, Taupin JL, Moreau JF, Hoflack B, Minvielle S, Jacques Y, Godard A 1998 The mannose 6-phosphate/ insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factory. J Biol Chem 273:20886-20893
13. Blanchard F, Duplomb L, Raher S, Vusio P, Hoflack B, Jacques Y, Godard A 1999 Mannose 6-phosphate/insulin-like growth factor II receptor mediates internalizarion and degradation of leukemia inhibitory factor but not signal transduction. J Biol Chem 274:24685-24693
14. Kornfeld S 1992 Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61:307-330
15. Kiess W, Blickenstaff GD, Sklar MM, Thomas CL, Nissley SP, Sahagian GG 1988 Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. J Biol Chem 263:9339-9344
16. Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C, Stockinger H 1999 M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-β1. Eur J Immunol 29:1004-1013
17. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, Efstratiadis A 1996 Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517-535
18. Wang S, Souza RF, Kong D, Yin J, Smolinski KN, Zou TT, Frank T, Young J, Flanders KC, Sugimura H, Abraham JM, Meltzer SJ 1997 Deficient transforming growth factor-β1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res 57:2543-2546
19. Gaidano G, Hauptschein RS, Parsa NZ, Off it K, Rao PH, Lenoir G, Knowles DM, Chaganti RS, Dalla-Favera R 1992 Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80:1781
20. Scalia P, Heart E, Comai L, Vigneri R, Sung CK 2001 Regulation of the Akt/glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A. J Cell Biochem 82:610-618
21. Schwartz GN, Warren MK, Sakano K, Szabo JM, Kessler SW, Pashapour A, Gress RE, Perdue JF 1996 Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis. Stem Cells 14:337-350
22. Leverrier Y, Thomas J, Mathieu AL, Low W, Blanquier B, Marvel J 1999 Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ 6:290-296
23. Zumkeller W, Burdach S 1999 The insulin-like growth factor system in normal and malignant hematopoietic cells. Blood 94:3653-3657
24. Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H 2001 Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Oncogene 20: 88-96
25. Bobek G, Scott CD, Baxter RC 1992 Radioimmunoassay of soluble insulin-like growth factor-II/mannose 6-phosphate receptor: developmental regulation of receptor release by rat tissues in culture. Endocrinology 130:3387-3394
26. Costello M, Baxter RC, Scott CD 1999 Regulation of soluble insulin-like growth factor II/mannose 6-phosphate receptor in human serum: measurement by enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 84: 611-617
27. Scott CD, Weiss J 2000 Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. J Cell Physiol 182:62-68
28. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau JF, Bataille R, Minvielle S, Jacques Y 1995 Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 86:2534-2540
29. Lebeau B, Montero Julian FA, Wijdenes J, Muller-Newen G, Dahmen H, Cherel M, Heinrich PC, Brailly H, Hallet MM, Godard A, Minvielle S, Jacques Y 1997 Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett 407:141-147
30. Moreau JF, Donaldson DD, Bennett F, Witek-Giannotti J, Clark SC, Wong GG 1988 Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336:690-692
31. Godard A, Heymann D, Raher S, Anegon I, Peyrat MA, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou JP, Moreau JF, Jacques Y 1992 High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J Biol Chem 267:3214-3222
32. Hoflack B, Fujimoto K, Kornfeld S 1987 The interaction of phosphorylated oligosaccharides and lysosomal enzymes with bovine liver cation-dependent mannose 6-phosphate receptor. J Biol Chem 262:123-129
33. Blanchard F, Wang Y, Kinzie E, Duplomb L, Godard A, Baumann H 2001 Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms. J Biol Chem 276:47038-47045
34. Schwab G, Siegall CB, Aarden LA, Neckers LM, Nordan RP 1991 Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood 77:587-593
35. Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, Godard A, Jacques Y, Baumann H 2000 Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275:28793-28801
36. Tu Y, Gardner A, Lichtenstein A 2000 The phosphatidylinositol 3-kinase/ AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 60:6763-6770
37. Ogata A, Chauhan D, Urashima M, Teoh G, Treon SP, Anderson KC 1997 Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. Clin Cancer Res 3:1017-1022
38. Miyagawa S, Kobayashi M, Konishi N, Sato T, Ueda K 2000 Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors. Br J Haematol 109: 555-562
39. Scott CD, Baxter RC 1996 Regulation of soluble insulin-like growth factor-II/mannose 6-phosphate receptor in hepatocytes from intact and regenerating rat liver. Endocrinology 137:3864-3870
40. Li M, Distler JJ, Jourdian GW 1991 Isolation and characterization of mannose 6-phosphate/insulin-like growth factor II receptor from bovine serum. Glycobiology 1:511-517
41. Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjerg A 2003 Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab 88:132
42. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73
43. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447-449
44. Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP 1998 Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91:2475-2481
45. Correa PN, Eskinazi D, Axelrad AA 1994 Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 83:99-112
46. Hermouet S, Godard A, Pineau D, Corre I, Raher S, Lippert E, Jacques Y 2002 Abnormal production of interleukin (IL)-11 and IL-8 in polycythemia vera. Cytokine 20:178-183
47. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC 2000 Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103:491-500
48. Vignon F, Rochefort H 1992 Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor. Breast Cancer Res Treat 22:47-57